The consumption of cardiovascular system medicines in the Netherlands demonstrated a steady rise from 2013 to 2022, reaching 462.5 Defined Daily Dosages (DDD) per thousand persons per day in 2023. The year-on-year percentage variation for 2023 stood at 0.39%, while the compound annual growth rate (CAGR) over the last five years (2018-2023) averaged 0.55%. This period showed mild but consistent growth, with anomalies such as the slight decline in 2020.
Future trends point towards continued, albeit slow, growth in medicine usage. The forecasted CAGR from 2024 to 2028 is projected at 0.2%, indicating a continued increase in usage, albeit at a more modest pace. In 2028, the usage is estimated to reach approximately 468.8 DDD per thousand persons per day. Important trends to watch for include the impacts of aging populations, advancements in cardiovascular treatments, and public health interventions aimed at reducing disease incidence.
